Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gerald Gimpl is active.

Publication


Featured researches published by Gerald Gimpl.


Neuroscience Letters | 1992

Bradykinin receptors in cultured astrocytes from neonatal rat brain are linked to physiological responses

Gerald Gimpl; Wolfgang Walz; Carsten Ohlemeyer; Helmut Kettenmann

Specific binding sites for bradykinin (BK) have recently been demonstrated on astrocytes of primary cultures from neonatal rat brain. In this study we demonstrate that BK induces membrane currents in concert with an elevation of [Ca2+]i. In 67% of astrocytes, BK induced an inward current as determined with the perforated patch-clamp technique in the whole-cell recording configuration. In a small population of astrocytes (20%), a BK-activated outward current was observed, while in the remainder of the cells (13%) no apparent current responses were detected. As recorded by fura-2 microfluorimetry, the peptide induced a transient rise of [Ca2+/bdi even when the extracellular calcium was removed. In the majority of astrocytes, the selective B1-agonist des-Arg9-BK elicited physiological responses with a much lower potency, indicating that the BK receptors are predominantly of the B2 subtype. A minor population of astrocytes was present which only responded to des-Arg9-BK.


Journal of Biological Chemistry | 2011

Unsaturated Fatty Acids Drive Disintegrin and Metalloproteinase (ADAM)-dependent Cell Adhesion, Proliferation, and Migration by Modulating Membrane Fluidity

Karina Reiss; Isabell Cornelsen; Matthias Husmann; Gerald Gimpl; Sucharit Bhakdi

The disintegrin-metalloproteinases ADAM10 and ADAM17 mediate the release of several cell signaling molecules and cell adhesion molecules such as vascular endothelial cadherin or L-selectin affecting endothelial permeability and leukocyte transmigration. Dysregulation of ADAM activity may contribute to the pathogenesis of vascular diseases, but the mechanisms underlying the control of ADAM functions are still incompletely understood. Atherosclerosis is characterized by lipid plaque formation and local accumulation of unsaturated free fatty acids (FFA). Here, we show that unsaturated FFA increase ADAM-mediated substrate cleavage. We demonstrate that these alterations are not due to genuine changes in enzyme activity, but correlate with changes in membrane fluidity as revealed by measurement of 1,6-diphenyl-1,3,5-hexatriene fluorescence anisotropy and fluorescence recovery after photobleaching analyses. ELISA and immunoblot experiments conducted with granulocytes, endothelial cells, and keratinocytes revealed rapid increase of ectodomain shedding of ADAM10 and ADAM17 substrates upon membrane fluidization. Large amounts of unsaturated FFA may be liberated from cholesteryl esters in LDL that is entrapped in atherosclerotic lesions. Incubation of cells with thus modified LDL resulted in rapid cleavage of ADAM substrates with corresponding functional consequences on cell proliferation, cell migration, and endothelial permeability, events of high significance in atherogenesis. We propose that FFA represent critical regulators of ADAM function that may assume relevance in many biological settings through their influence on mobility of enzyme and substrate in lipid bilayers.


Journal of Biological Chemistry | 2012

Melittin modulates keratinocyte function through P2 receptor-dependent ADAM activation.

Anselm Sommer; Anja Fries; Isabell Cornelsen; Nancy A. Speck; Friedrich Koch-Nolte; Gerald Gimpl; Jörg Andrä; Sucharit Bhakdi; Karina Reiss

Background: Melittin is an antimicrobial peptide that is also being considered as anti-inflammatory and anti-cancer agent. Results: Melittin provokes P2 receptor activation, which leads to ADAM-dependent transactivation of the EGFR and augments keratinocyte proliferation and migration. Conclusion: Melittin modulates cellular functions through activation of ADAM-mediated shedding. Significance: The use of melittin may elicit unexpected and unwanted effects via ADAM activation. Melittin, the major component of the bee venom, is an amphipathic, cationic peptide with a wide spectrum of biological properties that is being considered as an anti-inflammatory and anti-cancer agent. It modulates multiple cellular functions but the underlying mechanisms are not clearly understood. Here, we report that melittin activates disintegrin-like metalloproteases (ADAMs) and that downstream events likely contribute to the biological effects evoked by the peptide. Melittin stimulated the proteolysis of ADAM10 and ADAM17 substrates in human neutrophil granulocytes, endothelial cells and murine fibroblasts. In human HaCaT keratinocytes, melittin induced shedding of the adhesion molecule E-cadherin and release of TGF-α, which was accompanied by transactivation of the EGF receptor and ERK1/2 phosphorylation. This was followed by functional consequences such as increased keratinocyte proliferation and enhanced cell migration. Evidence is provided that ATP release and activation of purinergic P2 receptors are involved in melittin-induced ADAM activation. E-cadherin shedding and EGFR phosphorylation were dose-dependently reduced in the presence of ATPases or P2 receptor antagonists. The involvement of P2 receptors was underscored in experiments with HEK cells, which lack the P2X7 receptor and showed strikingly increased response to melittin stimulation after transfection with this receptor. Our study provides new insight into the mechanism of melittin function which should be of interest particularly in the context of its potential use as an anti-inflammatory or anti-cancer agent.


Biochemical Journal | 2011

Cholesterol-induced conformational changes in the oxytocin receptor.

Sabine Muth; Anja Fries; Gerald Gimpl

Recent studies suggest that cholesterol binding is widespread among GPCRs (G-protein-coupled receptors). In the present study, we analysed putative cholesterol-induced changes in the OTR [OT (oxytocin) receptor], a prototype of cholesterol-interacting GPCRs. For this purpose, we have created recombinant OTRs that are able to bind two small-sized fluorescence-labelled ligands simultaneously. An OTR antagonist was chosen as one of the ligands. To create a second ligand-binding site, a small-sized α-BTB (bungarotoxin binding) site was inserted at the N-terminus or within the third extracellular loop of the OTR. All receptor constructs were functionally active and bound both ligands with high affinity in the nanomolar range. Measurements of the quenching behaviour, fluorescence anisotropy and energy transfer of both receptor-bound ligands were performed to monitor receptor states at various cholesterol concentrations. The quenching studies suggested no major changes in the molecular environment of the fluorophores in response to cholesterol. The fluorescence anisotropy data indicated that cholesterol affects the dynamics or orientation of the antagonist. The energy transfer efficiency between both ligands clearly increased with increasing cholesterol. Overall, cholesterol induced both a changed orientation and a decreased distance of the receptor-bound ligands, suggesting a more compact receptor state in association with cholesterol.


FEBS Letters | 1991

Identification of a receptor protein for neuropeptide Y in rabbit kidney. G-protein association and inhibition of adenylate cyclase.

Gerald Gimpl; Jochen Wahl; Rudolf E. Lang

We previously identified the receptor for neuropeptide Y (NPY) on rabbit kidney membranes as a 100 kDa protein [(1990) J. Biol. Chem. 265, 18142–18143]. It is demonstrated in this study that the stable guanine nucleotide analogue, guanosine 5′‐O‐(3‐thiotriphosphate)(GTPγS), is capable of decreasing the labeling of the 100 kDa protein in a concentration‐dependent manner, with an IC20 value of 50 μM. This suggests that the 100 kDa protein represents a G‐protein coupled receptor type. In isolated proximal tubulex from rabbit kidney NPY decreases the parathyroid hormone stimulated cAMP production in a dose‐dependent fashion. This indicates that the NPY receptor in rabbit kidney is negatively coupled to adenylate cyclase by a G1‐like protein.


Journal of Neuroscience Research | 1994

Extracellular ATP-induced currents in astrocytes: involvement of a cation channel.

W. Walz; Gerald Gimpl; Carsten Ohlemeyer; Helmut Kettenmann


Journal of Neuroscience Research | 1993

Identification of neuropeptide Y receptors in cultured astrocytes from neonatal rat brain

Gerald Gimpl; Frank Kirchhoff; R. E. Lang; Helmut Kettenmann


Journal of Biological Chemistry | 1990

Solubilization and Characterization of Active Neuropeptide Y Receptors from Rabbit Kidney

Gerald Gimpl; Rüdiger Gerstberger; Ursula Mauss; Karl-Norbert Klotz; Rudolf E. Lang


Annals of the New York Academy of Sciences | 1990

Importance of Neuropeptide Y in the Regulation of Kidney Functiona

Pontus B. Persson; Gerald Gimpl; Rudolf E. Lang


Archive | 2012

Melittin Modulates Keratinocyte Function through P2

Anselm Sommer; Anja Fries; Isabell Cornelsen; Nancy A. Speck; Friedrich Koch-Nolte; Gerald Gimpl; Jörg Andrä; Sucharit Bhakdi; Karina Reiss; Fromthe ‡ DepartmentofDermatology

Collaboration


Dive into the Gerald Gimpl's collaboration.

Top Co-Authors

Avatar

Helmut Kettenmann

Max Delbrück Center for Molecular Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Carsten Ohlemeyer

Max Delbrück Center for Molecular Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nancy A. Speck

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge